142 related articles for article (PubMed ID: 38636681)
1. Comprehensive understanding of the role of GPER in estrogen receptor-alpha negative breast cancer.
Abbas MA; Al-Kabariti AY; Sutton C
J Steroid Biochem Mol Biol; 2024 Jul; 241():106523. PubMed ID: 38636681
[TBL] [Abstract][Full Text] [Related]
2. Bisphenol AF exerts estrogenic activity in MCF-7 cells through activation of Erk and PI3K/Akt signals via GPER signaling pathway.
Lei B; Sun S; Zhang X; Feng C; Xu J; Wen Y; Huang Y; Wu M; Yu Y
Chemosphere; 2019 Apr; 220():362-370. PubMed ID: 30590302
[TBL] [Abstract][Full Text] [Related]
3. Disruption of 3D MCF-12A breast cell cultures by estrogens--an in vitro model for ER-mediated changes indicative of hormonal carcinogenesis.
Marchese S; Silva E
PLoS One; 2012; 7(10):e45767. PubMed ID: 23056216
[TBL] [Abstract][Full Text] [Related]
4. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
[TBL] [Abstract][Full Text] [Related]
5. MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.
Lappano R; Santolla MF; Pupo M; Sinicropi MS; Caruso A; Rosano C; Maggiolini M
Breast Cancer Res; 2012 Jan; 14(1):R12. PubMed ID: 22251451
[TBL] [Abstract][Full Text] [Related]
6. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
Zekas E; Prossnitz ER
BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
[TBL] [Abstract][Full Text] [Related]
7. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.
Li Y; Birnbaumer L; Teng CT
Mol Endocrinol; 2010 May; 24(5):969-80. PubMed ID: 20211987
[TBL] [Abstract][Full Text] [Related]
8. AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs).
Cirillo F; Lappano R; Bruno L; Rizzuti B; Grande F; Guzzi R; Briguori S; Miglietta AM; Nakajima M; Di Martino MT; Maggiolini M
J Exp Clin Cancer Res; 2019 Aug; 38(1):335. PubMed ID: 31370872
[TBL] [Abstract][Full Text] [Related]
9. Two novel GPER agonists induce gene expression changes and growth effects in cancer cells.
Lappano R; Rosano C; Santolla MF; Pupo M; De Francesco EM; De Marco P; Ponassi M; Spallarossa A; Ranise A; Maggiolini M
Curr Cancer Drug Targets; 2012 Jun; 12(5):531-42. PubMed ID: 22414008
[TBL] [Abstract][Full Text] [Related]
10. ER-mediated anti-tumor effects of shikonin on breast cancer.
Yang Y; Gao W; Tao S; Wang Y; Niu J; Zhao P; Rao C; Yang L
Eur J Pharmacol; 2019 Nov; 863():172667. PubMed ID: 31545985
[TBL] [Abstract][Full Text] [Related]
11. Possible role of phytoestrogens in breast cancer via GPER-1/GPR30 signaling.
Molina L; Bustamante FA; Bhoola KD; Figueroa CD; Ehrenfeld P
Clin Sci (Lond); 2018 Dec; 132(24):2583-2598. PubMed ID: 30545896
[TBL] [Abstract][Full Text] [Related]
12. GPER-1/GPR30 a novel estrogen receptor sited in the cell membrane: therapeutic coupling to breast cancer.
Molina L; Figueroa CD; Bhoola KD; Ehrenfeld P
Expert Opin Ther Targets; 2017 Aug; 21(8):755-766. PubMed ID: 28671018
[TBL] [Abstract][Full Text] [Related]
13. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.
Meng R; Qin Q; Xiong Y; Wang Y; Zheng J; Zhao Y; Tao T; Wang Q; Liu H; Wang S; Jiang WG; He J
Oncotarget; 2016 Aug; 7(34):54983-54997. PubMed ID: 27448983
[TBL] [Abstract][Full Text] [Related]
14. Perfluoroalkyl substances promote breast cancer progression via ERα and GPER mediated PI3K/Akt and MAPK/Erk signaling pathways.
Liu Q; Liu Y; Li X; Wang D; Zhang A; Pang J; He J; Chen X; Tang NJ
Ecotoxicol Environ Saf; 2023 Jun; 258():114980. PubMed ID: 37148752
[TBL] [Abstract][Full Text] [Related]
15. Triclocarban and triclosan promote breast cancer progression in vitro and in vivo via activating G protein-coupled estrogen receptor signaling pathways.
He TT; Li X; Ma JZ; Yang Y; Zhu S; Zeng J; Luo L; Yin YL; Cao LY
Sci Total Environ; 2024 Jun; 931():172782. PubMed ID: 38679099
[TBL] [Abstract][Full Text] [Related]
16. Proteolytic Targeting Chimeras with Specificity for Plasma Membrane and Intracellular Estrogen Receptors.
Lu AS; Rouhimoghadam M; Arnatt CK; Filardo EJ; Salem AK
Mol Pharm; 2021 Mar; 18(3):1455-1469. PubMed ID: 33600191
[TBL] [Abstract][Full Text] [Related]
17. Bisphenol AF-induced endogenous transcription is mediated by ERα and ERK1/2 activation in human breast cancer cells.
Li M; Guo J; Gao W; Yu J; Han X; Zhang J; Shao B
PLoS One; 2014; 9(4):e94725. PubMed ID: 24727858
[TBL] [Abstract][Full Text] [Related]
18. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M
Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773
[TBL] [Abstract][Full Text] [Related]
19. Oleuropein and hydroxytyrosol activate GPER/ GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells.
Chimento A; Casaburi I; Rosano C; Avena P; De Luca A; Campana C; Martire E; Santolla MF; Maggiolini M; Pezzi V; Sirianni R
Mol Nutr Food Res; 2014 Mar; 58(3):478-89. PubMed ID: 24019118
[TBL] [Abstract][Full Text] [Related]
20. G Protein-Coupled Estrogen Receptor Mediates Cell Proliferation through the cAMP/PKA/CREB Pathway in Murine Bone Marrow Mesenchymal Stem Cells.
Chuang SC; Chen CH; Chou YS; Ho ML; Chang JK
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
